Barclays: The IDEXX Laboratories (IDXX.US) rating was maintained, and the target price was adjusted from $655.00 to $570.00.
巴克莱：维持IDEXX Laboratories(IDXX.US)评级，由增持调整至增持评级, 目标价由655.00美元调整至570.00美元。
Barclays: The IDEXX Laboratories (IDXX.US) rating was maintained, and the target price was adjusted from $655.00 to $570.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.